Article

ASCRS 2020: Real-world efficacy of DEXYCU data retrospective case study

Author(s):

Alex Delaney-Gesing
Conferences|ASCRS

Ophthalmology Times' David Hutton speaks with Cynthia Matossian, MD, FACS, on her presentation "Real-world efficacy of DEXYCU (dexamethasone intraocular suspension) 9% retrospective case study data" during the 2020 ASCRS virtual meeting.

 

See more ASCRS conference coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
Related Content
(Image credit: Ophthalmology Times) From firsts to the future: A pioneer's perspective on ophthalmology
August 22nd 2025

From firsts to the future: A pioneer's perspective on ophthalmology

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 22nd 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Navigate successful cataract surgery with refractive technology
August 22nd 2025

Navigate successful cataract surgery with refractive technology

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 22nd 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image courtesy of New York Eye and Ear Infirmary of Mount Sinai) Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE
August 22nd 2025

Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE

(Image credit: Mount Sinai NYEE) Mount Sinai’s NYEE unveils Center for Refractive Solutions
August 22nd 2025

Mount Sinai’s NYEE unveils Center for Refractive Solutions

© 2025 MJH Life Sciences

All rights reserved.